4731133
Description
Mind Map by oliviayinli, updated more than 1 year ago
|
Created by oliviayinli
almost 9 years ago
|
|
Diabetes Mellitus
Type II
- Pathophysiology
- Risk Factors
- Pre-diabetes
- Impaired glucose
tolerance (IGT)
- 2h OGTT: 7.8-11.1 mmol/L
(ADA, 2004)
- 2h OGTT: 7.8-11.1 mmol/L
(ADA, 2004)
- Impaired fasting
glucose (IFG)
- FPG 5.6-6.9 mmol/L
(ADA, 2004)
- FPG 5.6-6.9 mmol/L
(ADA, 2004)
- Impaired glucose
tolerance (IGT)
- Genetics
- Obesity
- Aging
- Metabolic Syndrome
(Grundy et al., 2004)
- Dyslipidemia
- Abdominal obesity
- Dyslipidemia
- Pre-diabetes
- Diagnosis
- CLINICAL MANIFESTATIONS
- MANAGEMENT
- PHARMACOLOGICAL
- Insulin
- Preparations
- rapid-acting: peak 1.5-2.5h
- short-acting (regular): peak 2-4h
- Intermediate (NPH - cloudy): peak 6-8h
- Long-acting: no peak
- rapid-acting: peak 1.5-2.5h
- Admin
- self-admin
- subcutaneous
- abdomen,
buttocks,
thigh, deltoid
- rotate
injection
sites
- rotate
injection
sites
- abdomen,
buttocks,
thigh, deltoid
- intravenous
- self-admin
- Preparations
- Oral Anti-hyperglycemic Agents
- α-glucosidase
inhibitors
- mech: slow
carb digestion
- mech: slow
carb digestion
- DPP-4 inhibitors
- mech: slow incretin
hormone
inactivation
- mech: slow incretin
hormone
inactivation
- Biguinides (i.e.
metformin)
- FIRST-LINE OHA TREATMENT!
(Nathan et al., 2009; Inzucchi
et al., 2012)
- FIRST-LINE OHA TREATMENT!
(Nathan et al., 2009; Inzucchi
et al., 2012)
- Thiazolidinediones
- mech: decrease
insulin resistance
- mech: decrease
insulin resistance
- sulphonylureas
- metglitinides
- mech: increase insulin
production by β cells
- mech: increase insulin
production by β cells
- α-glucosidase
inhibitors
- Insulin
- STRESS MANAGEMENT
(Surwit et al., 2002)
- Muscle
Relaxation
- Cognitive
Behavioural
- Recognizing
stressors
- Guided
imagery
- Recognizing
stressors
- Muscle
Relaxation
- EXERCISE
- 150 min/week
moderate
intensity
- Mechs
- ↓ blood glucose
- ↑ insulin sensitivity
- weight loss
- ↓ blood glucose
- 150 min/week
moderate
intensity
- NUTRITION
- Diet Teaching
- Personalized diet
planning (Inzucchi
et al., 2012)
- Fat <7% of
daily intake
- Carbs < 10% of
daily intake
from sucrose
- Protein:
15-20% of
daily intake
- Personalized diet
planning (Inzucchi
et al., 2012)
- Diet Teaching
- PHARMACOLOGICAL
- Nursing Considerations
- Nursing Process
- 1. Assessment
- Learning needs,
motivation and
the ability to learn
- Physical history
- BMI, height, weight, vital signs
- Current medication
- Past surgical procedure
- History of infection
- BMI, height, weight, vital signs
- Lifestyle
- Stress
- Exercise
- Stress
- Learning needs,
motivation and
the ability to learn
- 2. Plan
- Determine goals
and expected
outcome with the
patient
- Setting priorities
- Learning objectives
- Selecting teaching methods
- Setting priorities
- Determine goals
and expected
outcome with the
patient
- 3. Implementation
- Home care
- Importance of
medication
adherence
- Travel
- Adequate medication
- Diabetic medical bracelet
- Adequate medication
- Importance of
medication
adherence
- Health promotion
- Patient education
- Diet
- Define the disease
- Purposeful factiities
that can control the
disease
- Self monitoring blood glucose
- Important resources
- Diet
- Patient education
- Home care
- 4. Evaluation
- Patient understanding
- Up-to-date immunizations
- Up-to-date immunizations
- Patient understanding
- 1. Assessment
- Nursing Process
Want to create your own Mind Maps for free with GoConqr? Learn more.